| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | SB INVESTMENT ADVISERS (UK) LTD | 65.93M (17.78%) | -5.43M Decreased by -8.23% | Sep 30, 24 |
| 2 | Qvt Financial LP | 65.79M (17.74%) | -926.00K Decreased by -1.41% | Sep 30, 24 |
| 3 | Viking Global Investors LP | 54.10M (14.59%) | -15.06M Decreased by -27.83% | Sep 30, 24 |
| 4 | FMR Inc | 49.15M (13.25%) | 2.59M Increased by +5.28% | Sep 30, 24 |
| 5 | BlackRock Inc | 41.96M (11.32%) | 6.59M Increased by +15.71% | Sep 30, 24 |
| 6 | Vanguard Group Inc | 41.68M (11.24%) | 33.49M Increased by +80.35% | Sep 30, 24 |
| 7 | Morgan Stanley - Brokerage Accounts | 29.67M (8.00%) | -28.99M Decreased by -97.68% | Sep 30, 24 |
| 8 | Rubric Capital Management LP | 22.40M (6.04%) | -600.00K Decreased by -2.68% | Sep 30, 24 |
| 9 | State Street Corp | 19.56M (5.28%) | 1.12M Increased by +5.72% | Sep 30, 24 |
| 10 | State Street Corporation | 17.15M (4.63%) | 3.43M Increased by +19.97% | Mar 31, 24 |
| 11 | Wellington Management Company LLP | 13.64M (3.68%) | -1.20M Decreased by -8.82% | Dec 31, 23 |
| 12 | Patient Square Capital | 12.23M (3.30%) | 0.00 Increased by 0.00% | Sep 30, 24 |
| 13 | T. Rowe Price Investment Management,Inc. | 10.65M (2.87%) | 10.65M Increased by +100.00% | Sep 30, 23 |
| 14 | Two Seas Capital LP | 9.72M (2.62%) | -593.87K Decreased by -6.11% | Sep 30, 24 |
| 15 | Woodline Partners LP | 8.69M (2.34%) | 685.54K Increased by +7.89% | Sep 30, 24 |
| 16 | Geode Capital Management, LLC | 7.75M (2.09%) | 1.46M Increased by +18.85% | Sep 30, 24 |
| 17 | Baker Bros Advisors LP | 7.41M (2.00%) | -179.19K Decreased by -2.42% | Mar 31, 24 |
| 18 | Farallon Capital Management, L.L.C. | 7.34M (1.98%) | 3.48M Increased by +47.47% | Dec 31, 23 |
| 19 | Amvescap Plc. | 6.36M (1.71%) | 447.39K Increased by +7.04% | Sep 30, 24 |
| 20 | Citadel Advisors Llc | 5.93M (1.60%) | 4.00M Increased by +67.54% | Sep 30, 24 |
| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | Fidelity Growth Compy Commingled Pl S | 22.40M (6.04%) | 296.05K Increased by +1.32% | Dec 31, 24 |
| 2 | Fidelity Growth Compy Commingled Pl O | 21.15M (5.70%) | 439.20K Increased by +2.08% | Aug 31, 24 |
| 3 | Fidelity Growth Company Fund | 15.77M (4.25%) | -277.59K Decreased by -1.76% | Dec 31, 24 |
| 4 | Vanguard Total Stock Mkt Idx Inv | 14.71M (3.97%) | 746.94K Increased by +5.08% | Dec 31, 24 |
| 5 | iShares Core S&P Mid-Cap ETF | 14.02M (3.78%) | -3.65K Decreased by -0.03% | Jan 31, 25 |
| 6 | Vanguard Small Cap Index | 12.05M (3.25%) | 851.68K Increased by +7.07% | Dec 31, 24 |
| 7 | Fidelity® Growth Company | 10.84M (2.92%) | 288.60K Increased by +2.66% | Nov 30, 23 |
| 8 | Vanguard Health Care Inv | 9.57M (2.58%) | 0.00 Increased by 0.00% | Dec 31, 23 |
| 9 | SPDR® S&P Biotech ETF | 7.69M (2.07%) | -74.75K Decreased by -0.97% | Jan 31, 25 |
| 10 | Invesco S&P MidCap Quality ETF | 6.95M (1.87%) | 27.26K Increased by +0.39% | Jan 31, 25 |
| 11 | Vanguard Small Cap Growth Index Inv | 6.83M (1.84%) | 676.48K Increased by +9.90% | Dec 31, 24 |
| 12 | Vanguard Institutional Extnd Mkt Idx Tr | 6.47M (1.74%) | -47.50K Decreased by -0.73% | Dec 31, 24 |
| 13 | T. Rowe Price Mid-Cap Growth | 5.25M (1.42%) | 5.25M Increased by +100.00% | Sep 30, 23 |
| 14 | T. Rowe Price US Mid-Cap Growth Equity | 5.25M (1.42%) | 5.25M Increased by +100.00% | Sep 30, 23 |
| 15 | Fidelity Growth Company K6 | 5.06M (1.37%) | -94.86K Decreased by -1.87% | Dec 31, 24 |
| 16 | Fidelity® Select Biotechnology | 4.60M (1.24%) | 61.10K Increased by +1.33% | Nov 30, 23 |
| 17 | Fidelity Series Growth Company | 3.73M (1.01%) | -350.90K Decreased by -9.41% | Dec 31, 24 |
| 18 | Fidelity® Growth Company K6 | 3.63M (0.98%) | -389.86K Decreased by -10.74% | Nov 30, 23 |
| 19 | MS INVF US Advantage I | 3.62M (0.98%) | 0.00 Increased by 0.00% | Sep 30, 24 |
| 20 | SPDR® S&P MIDCAP 400 ETF Trust | 3.58M (0.97%) | 43.22K Increased by +1.21% | Dec 31, 24 |